摘要
目的探讨围生期心肌病的临床特点及治疗效果。方法对18例围生期心肌病患者进行回顾性总结，并结合文献进行讨论。结果本组病例≥30岁者8例，经产妇8例，误诊为妊娠期高血压性心脏病1例，3例因输血输液加重病情，3例使用低分子肝素抗凝治疗。结果16例好转，死亡2例。结论围生期心肌病多见于高龄妊娠及经产妇，诊断应与妊娠高血压性心脏病鉴别，治疗主要是控制心衰，有指征者应抗凝治疗，难治性心衰是死亡的主要原因。
Objective To discuss the clinical characteristics and therapeutic efficacy of erinatal period cardiomyopathy. Methods Summarize the 18 cases of perinatal period cardiomyopathy retrospectively. Results 8 patients were older than 30, 8 patients were multipara, 1 case was misdiagnosed to gestational period hypertensive heart disease, the pathogenetic condition of 3 cases were aggravated because of blood transfusion, 3 patients were treated with Low Molecular Heparin. The therapeutic result was that 16 cases were improved and 2 patients died. Conclusions Perinatal period cardiomyopathies are mostly onset in eld pregnancy and multipara, and should be discriminated from gestational period hypertensive heart disease. The therapeutic principle is to control heart failure, anticoagulant therapy if necessary. The refractoriness congestive heart failure is the main cause of death.
出处
《世界感染杂志》
2009年第5期333-334,共2页
World Journal of Infection
关键词
围生期心肌病
诊治
抗凝治疗
心衰
perinatal period cardiomyopathy
diagnosis and treatment
anticoagulant therapy
congestiveheart failure.
